Use of a flowable haemostat versus an oxidised regenerated cellulose agent in primary elective cardiac surgery: economic impact from a UK healthcare perspective
Crossref DOI link: https://doi.org/10.1186/s13019-017-0660-y
Published Online: 2017-11-29
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Joshi, Mayur R.
Latham, Jacqueline http://orcid.org/0000-0001-6392-513X
Okorogheye, Gabriel
Funding for this research was provided by:
Baxter Healthcare Ltd